ProfileGDS4718 / 232017_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 82% 64% 83% 83% 78% 80% 75% 83% 81% 78% 81% 78% 79% 76% 85% 74% 81% 77% 88% 83% 78% 72% 84% 81% 76% 85% 88% 85% 75% 79% 81% 88% 79% 82% 78% 74% 84% 80% 60% 76% 80% 79% 76% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6607886
GSM549102patient 115, normal, homogenized [OPG study]8.0623382
GSM549104patient 119, normal, homogenized [OPG study]6.4072964
GSM549108patient 138, normal, homogenized [OPG study]8.1183183
GSM549119patient 077, normal, homogenized [OPG study]8.2210883
GSM549133patient 032, cancer, homogenized [OPG study]7.8097378
GSM549139patient 042, cancer, homogenized [OPG study]7.9134480
GSM549099patient 107, normal, homogenized [OPG study]7.250975
GSM549109patient 139, normal, homogenized [OPG study]8.1431783
GSM549110patient 046, normal, homogenized [OPG study]7.8951781
GSM549114patient 063, normal, homogenized [OPG study]7.6611678
GSM549122patient 082, normal, homogenized [OPG study]7.9539181
GSM549134patient 033, cancer, homogenized [OPG study]7.6849778
GSM549136patient 036, cancer, homogenized [OPG study]7.8372879
GSM549140patient 044, cancer, homogenized [OPG study]7.5463676
GSM549111patient 047, normal, homogenized [OPG study]8.5762585
GSM549113patient 057, normal, homogenized [OPG study]7.2822274
GSM549132patient 031, cancer, homogenized [OPG study]7.9560581
GSM549137patient 038, cancer, homogenized [OPG study]7.5562377
GSM549142patient 047, cancer, homogenized [OPG study]8.4190788
GSM549100patient 110, normal, homogenized [OPG study]8.2046183
GSM549107patient 135, normal, homogenized [OPG study]7.612878
GSM549115patient 068, normal, homogenized [OPG study]7.1125572
GSM549116patient 072, normal, homogenized [OPG study]8.3942884
GSM549120patient 078, normal, homogenized [OPG study]7.9904981
GSM549131patient 030, cancer, homogenized [OPG study]7.5084276
GSM549118patient 074, normal, homogenized [OPG study]8.5036185
GSM549129patient 027, cancer, homogenized [OPG study]8.7992188
GSM549123patient 088, normal, homogenized [OPG study]8.4918685
GSM549124patient 006, cancer, homogenized [OPG study]7.272575
GSM549126patient 015, cancer, homogenized [OPG study]7.7307879
GSM549128patient 025, cancer, homogenized [OPG study]8.0381781
GSM549103patient 117, normal, homogenized [OPG study]8.8445988
GSM549117patient 073, normal, homogenized [OPG study]7.7904179
GSM549138patient 041, cancer, homogenized [OPG study]8.1462982
GSM549141patient 045, cancer, homogenized [OPG study]7.8094878
GSM549130patient 028, cancer, homogenized [OPG study]7.2556374
GSM549101patient 111, normal, homogenized [OPG study]8.355984
GSM549105patient 128, normal, homogenized [OPG study]7.8132580
GSM549106patient 134, normal, homogenized [OPG study]6.1414760
GSM549112patient 048, normal, homogenized [OPG study]7.3878476
GSM549125patient 011, cancer, homogenized [OPG study]7.8095380
GSM549127patient 024, cancer, homogenized [OPG study]7.791279
GSM549135patient 035, cancer, homogenized [OPG study]7.5612376